Articles: 26.11 5 June 2015

Jardiance: the latest SGLT2 for the treatment of type 2 diabetes

Empagliflozin (Jardiance) is the third SGLT2 inhibitor available for the treatment of type 2 diabetes. Here we present the clinical data relating to its efficacy and adverse events.
Jardiance the latest SGLT2 for the treatment of type 2 diabetes

More details...

Just how safe is paracetamol? Studies question long-term use

Paracetamol has been around for a long time; it was first introduced in the 1950s and has been available “over the counter” since 1959. For many years we have recommended it as both an effective analgesic and antipyretic, and have felt secure in the knowledge …

More details...

Opportunity for integration lost in creation of new roles

Efforts to reorganise pharmacy to encourage the provision of medicines management and patient care created new roles for pharmacists but they remained outside mainstream primary care.
Opportunity for integration lost in creation of new roles

More details...

Treatment of rheumatic lesions with corticosteroid injections

Successful corticosteroid injections require correct diagnosis and sound technique. For GPs to acquire this skill confers great advantage to both patient and doctor.
Treatment of rheumatic lesions with corticosteroid injections

More details...

Urinary tract infections: diagnosis and management

Urinary tract infections are commonly seen in primary care. This review focuses on key points and recent guidelines on the diagnosis and management of bacterial infections.
Urinary tract infections diagnosis and management

More details...

Web design and marketing agency Leamington Spa